Search results
Accumulate Bharti Airtel; target of Rs 1,620: Prabhudas Lilladher
CNBC Awaaz· 3 days agoPrabhudas Lilladher recommended accumulate rating on Bharti Airtel with a target price of Rs 1,620...
Buy UltraTech Cement; target of Rs 13,000: Sharekhan
CNBC Awaaz· 3 days agoSharekhan is bullish on UltraTech Cement has recommended buy rating on the stock with a target price of Rs 13,000 in its research report dated June 28,...
Buy SRG Housing Finance; target of Rs 411: Profitmart
CNBC Awaaz· 2 days agoProfitmart is bullish on SRG Housing Finance has recommended buy rating on the stock with a target...
ETHealthworld to host third edition of India Diagnostics Summit - ET HealthWorld
The Economic Times· 6 days agoThe third edition of the India Diagnostics Summit 2024, is poised to be an unparalleled event centred on the theme 'Diagnosing Tomorrow: Advancing Healthcare Through Innovation'. This summit ...
Stock market update: Nifty Pharma index falls 0.16%
The Economic Times· 6 days agoThe Nifty Pharma index closed 0.16 per cent down at 19514.8.
Ajit Mishra from Religare Broking suggests buying these three stocks today
Business Standard India· 7 days agoMarkets edged higher as expected, gaining over half a percent. After a flat start, the Nifty...
India to manufacture medication for diabetes, obesity under PLI by 2026: Report
Firstpost· 5 days agoIncentives are being planned by India in 2026 to encourage domestic production of GLP-1 medications,...
India's T20 Triumph: From Anand Mahindra To Sundar Pichai; The Business Paradigm Joins The ICC World...
Free Press Journal· 4 days agoThe world's fifth-largest economy's business horizon also joined these jubilant celebrations online. Mahindra group head Anand Mahindra, who is known for his active participation online, took ...
Taking Stock: Market fails to hold record high; surges 6.5% in June
CNBC Awaaz· 5 days agoFor the week, BSE Sensex and Nifty50 index added 2 percent each, however, for the month of June...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
CNBC Awaaz· 2 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...